Individual Patient Expanded Access IND for the Treatment of Stroke

Status:

NO_LONGER_AVAILABLE

Individual Patient Expanded Access IND for the Treatment of Stroke

Lead Sponsor:

Hope Biosciences Research Foundation

Conditions:

Stroke

Stroke, Ischemic

Eligibility:

All Genders

Brief Summary

This protocol is part of an Individual Patient Expanded Access IND. The patient is an 84-year-old male with history of Ischemic Stroke of the Left Middle Cerebral Artery causing an acute posterior lef...

Detailed Description

This is an Individual Patient Expanded Access IND of autologous adipose derived Mesenchymal Stem Cells with the primary goal of treating 1 individual with Stroke who has exhausted all current treatmen...

Eligibility Criteria

Inclusion

Inclusion Criteria
Documented diagnosis Stroke.
Hemodynamically stable.
Exclusion Criteria
Any signs of active infection at the time of screening.
Subjects with coagulation disorders.
Other acute or chronic medical conditions that, in the opinion of the investigator, may increase the risks associated with study participation or HB-adMSCs administration.
Any abnormal, inexplicable laboratory result with no obvious cause defined.
Participation in other interventional research studies.
Unwillingness to return for follow-up visits.

Exclusion

Key Trial Info

Start Date :

Trial Type :

EXPANDED_ACCESS

End Date :

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT04907188

Last Update

September 29 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)